Cargando…

Passing the acid test? Evaluating the impact of national education initiatives to reduce proton pump inhibitor use in Australia

BACKGROUND: Proton pump inhibitor (PPI) use is widespread. There have been increasing concerns about overuse of high-dose PPIs for durations longer than clinically necessary. OBJECTIVE: To evaluate the impact of national education initiatives on reducing PPI use in Australia. DESIGN: Population-base...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bruno, Claudia, Pearson, Sallie-Anne, Daniels, Benjamin, Buckley, Nicholas A, Schaffer, Andrea, Zoega, Helga
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7241967/ https://www.ncbi.nlm.nih.gov/pubmed/31641029 http://dx.doi.org/10.1136/bmjqs-2019-009897

Ejemplares similares

Long-term use of proton-pump inhibitors: whole-of-population patterns in Australia 2013–2016
por: Daniels, Benjamin, et al.
Publicado: (2020)

Choosing wisely? Quantifying the extent of three low value psychotropic prescribing practices in Australia
por: Brett, Jonathan, et al.
Publicado: (2018)

Changes in dispensing of medicines proposed for re-purposing in the first year of the COVID-19 pandemic in Australia
por: Schaffer, Andrea L., et al.
Publicado: (2022)

Comparison of Prescribing Patterns Before and After Implementation of a National Policy to Reduce Inappropriate Alprazolam Prescribing in Australia
por: Schaffer, Andrea L., et al.
Publicado: (2019)

Medicine treatment of glaucoma in Australia 2012–2019: prevalence, incidence and persistence
por: Daniels, Benjamin, et al.
Publicado: (2021)

Prescribed medicine use and extent of off‐label use according to age in a nationwide sample of Australian children
por: Schaffer, Andrea L., et al.
Publicado: (2022)

Anticholinergic medicines use among older adults before and after initiating dementia medicines
por: Narayan, Sujita W., et al.
Publicado: (2019)

Proton-pump inhibitors among adults: a nationwide drug-utilization study
por: Hálfdánarson, Óskar Ö., et al.
Publicado: (2018)

Impact of NPS MedicineWise general practitioner education programs and Choosing Wisely Australia recommendations on prescribing of proton pump inhibitors in Australia
por: Wu, Jianyun, et al.
Publicado: (2020)

Trends in dispensing and utilisation of sustained-release tapentadol in Australia.
por: Camacho, Ximena, et al.
Publicado: (2022)

Persistence and Adherence to Cardiovascular Medicines in Australia
por: de Oliveira Costa, Juliana, et al.
Publicado: (2023)

Changes in systemic cancer therapy in Australia during the COVID-19 pandemic: a population-based study
por: Tang, Monica, et al.
Publicado: (2021)

Expanded access to publicly subsidised lisdexamfetamine treatment for adults with attention-deficit/hyperactivity disorder: An interrupted time-series analysis
por: Bruno, Claudia, et al.
Publicado: (2023)

Opportunities for post-market surveillance of high cost medicines in Australia: Observing trastuzumab-treated women from early through late stage HER2-positive breast cancer (HER2BC)
por: Daniels, Benjamin, et al.
Publicado: (2017)

Generating Real-World Evidence on the Quality Use, Benefits and Safety of Medicines in Australia: History, Challenges and a Roadmap for the Future
por: Pearson, Sallie-Anne, et al.
Publicado: (2021)

Comparison of claims from high–drug cost beneficiaries in Ontario, Canada, and Australia: a cross-sectional analysis
por: Tadrous, Mina, et al.
Publicado: (2021)

Proton pump inhibitors and gastroenteritis
por: Hassing, Robert-Jan, et al.
Publicado: (2016)

Educational Intervention Improves Proton Pump Inhibitor Stewardship in Outpatient Gastroenterology Clinics
por: Walker, Megan J., et al.
Publicado: (2019)

Adherence to prescribing restrictions for HER2-positive metastatic breast cancer in Australia: A national population-based observational study (2001-2016)
por: Daniels, Benjamin, et al.
Publicado: (2018)

Proton Pumps: Molecular Mechanisms, Inhibitors and Activators of Proton Pumping
por: Siletsky, Sergey A.
Publicado: (2023)

A nationwide study of multimedicine use in people treated with cardiovascular medicines in Australia
por: Schaffer, Andrea L., et al.
Publicado: (2022)

Changes in antibiotic prescribing following COVID‐19 restrictions: Lessons for post‐pandemic antibiotic stewardship
por: Gillies, Malcolm B., et al.
Publicado: (2021)

Proton Pump Inhibitors and Gastritis
por: Suzuki, Masayuki, et al.
Publicado: (2008)

Deprescribing proton pump inhibitors
por: Teh, Kim Jun Kevin, et al.
Publicado: (2023)

Rapid and substantial increases in anticoagulant use and expenditure in Australia following the introduction of new types of oral anticoagulants
por: Morgan, Alice, et al.
Publicado: (2018)

Peer-Led Education Expedites Deprescribing Proton Pump Inhibitors for Appropriate Veterans
por: Bowman, Mary H.
Publicado: (2020)

Coronary by-pass for bad ventricle; adoption of "hybrid-pump" bypass
por: Nurözler, Feza, et al.
Publicado: (2006)

An educational intervention to optimize use of proton pump inhibitors in a Greek university hospital
por: Lazaridis, Lazaros-Dimitrios, et al.
Publicado: (2021)

Pharmacokinetics and Pharmacodynamics of the Proton Pump Inhibitors
por: Shin, Jai Moo, et al.
Publicado: (2013)

Proton pump inhibitors and hypomagnesemia monitoring
por: Lemon, Thomas I
Publicado: (2013)

Use and overuse of proton pump inhibitors
por: Staiano, Annamaria, et al.
Publicado: (2015)

Symptomatic hypomagnesemia and proton pump inhibitors
por: Tin, Sim Sai, et al.
Publicado: (2014)

Proton pump inhibitors and dysbiosis: Current knowledge and aspects to be clarified
por: Bruno, Giovanni, et al.
Publicado: (2019)

Trends in self-poisoning and psychotropic drug use in people aged 5–19 years: a population-based retrospective cohort study in Australia
por: Cairns, Rose, et al.
Publicado: (2019)

Risk of Pyogenic Liver Abscess in Proton Pump Inhibitor Users: New Inventory of Proton Pump Inhibitor Induced Complications?
por: Bang, Ki Bae
Publicado: (2021)

Large Hadron Collider passes first proton test
Publicado: (2008)

Management of laryngopharyngeal reflux with proton pump inhibitors
por: Reimer, Christina, et al.
Publicado: (2008)

Proton Pump Inhibitor Induced Depigmentation in Vitiligo
por: Holla, Anantha Prasad, et al.
Publicado: (2011)

Proton pump inhibitor-induced hypomagnesemic hypoparathyroidism
por: Swaminathan, Krishnan
Publicado: (2015)

Proton pump inhibitors: A balanced view
por: Ramakrishna, B.S.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_9iqo5blrb6ckn7e7a4rdupess6